NCT01739309 2023-09-21Study of LY2835219 for Mantle Cell LymphomaEli Lilly and CompanyPhase 2 Completed28 enrolled 20 charts
NCT02014129 2020-08-24A Study of LY2835219 in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed12 enrolled 11 charts